Delivery Order SPE2DB20D3303-SPE2DB25FA3GY
- Not listed
- The Defense Logistics Agency awarded a $6,081.01 delivery order to AmerisourceBergen Drug Corp for 60 tablets of Janumet 50-1,000 mg, a pharmaceutical product for diabetes management. This competitive award, issued on September 9, 2025, with an ultimate completion date of September 10, 2025, represents a firm fixed price delivery order with no set-aside designation. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters....
- The Defense Logistics Agency awarded a $3,095.75 firm fixed price delivery order to AmerisourceBergen Drug Corp for 60 tablets of Janumet 50-1,000 mg, a combination diabetes medication. The contract, which was not set aside and competitively awarded, was executed on September 17, 2025, with an ultimate completion date of September 18, 2025. AmerisourceBergen's corporate office in Conshohocken, Pennsylvania served as the place of performance for this pharmaceutical supply delivery supporting...
- The Defense Logistics Agency awarded a delivery order valued at $6,140.05 to AmerisourceBergen Drug Corp for 180-count tablets of Janumet 50-1,000 mg, a combination diabetes medication. The contract is a firm fixed-price delivery order with an ultimate completion date of September 12, 2025, and was awarded on September 11, 2025, with no set-aside designation. Performance will occur at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a $2,408.66 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 180 tablets of Janumet 50-1,000 mg, a combination medication used to treat type 2 diabetes. The contract, awarded on July 18, 2025, with an ultimate completion date of July 21, 2025, represents a non-competitive delivery order executed without set-aside provisions. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as the prime contractor and...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,610.07 to AmerisourceBergen Drug Corp on July 16, 2025, for the supply of Janumet 50-1,000 mg tablets (180-count units). This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of July 17, 2025. The pharmaceutical products will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $7,997.22 to AmerisourceBergen Drug Corp for 180 tablets of Janumet 50-1,000 mg on October 29, 2025, with completion scheduled for October 30, 2025. This competitively awarded, firm fixed-price delivery order was issued without a set-aside designation and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. Janumet is a combination antidiabetic medication used in the management of type 2...
- The Defense Logistics Agency awarded a $1,006.03 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 1,000 tablets of Janumet 50-1,000 mg, a pharmaceutical product used in diabetes management. The contract was awarded on September 23, 2025, with an ultimate completion date of September 24, 2025, and represents a non-set-aside, competitively awarded procurement. Performance will be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a $19,778.56 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 180 tablets of Janumet 50-1,000 mg on September 23, 2025, with an ultimate completion date of September 24, 2025. This non-competitive delivery order is being fulfilled from the contractor's place of business in Conshohocken, Pennsylvania. The award represents a continuation of AmerisourceBergen's role as a critical pharmaceutical supplier to the federal government, specifically...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Janumet 50-1,000 mg tablets (180-count units) with a ceiling value of $10,920.04. This competitively awarded, firm fixed-price delivery order represents a non-set-aside procurement and is scheduled for completion by September 11, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency awarded a delivery order valued at $1,448.64 to AmerisourceBergen Drug Corp for 180 tablets of Janumet 50-1,000 mg on April 21, 2025, with an ultimate completion date of April 22, 2025. This is a firm fixed-price delivery order with no set-aside designation, meaning it was competitively awarded. The product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters and primary distribution operations. This delivery...
- SPE2DB20D3303Indefinite Delivery Contract
- SPE2DB20D3303-SPE2DB25FA3GYDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $6,160.10 to AmerisourceBergen Drug Corp for 180 tablets of Janumet 50-1,000 mg, a combination medication used to treat type 2 diabetes. This firm fixed-price delivery order, awarded on September 4, 2025, represents a non-competitive set-aside award and is expected to be completed by September 5, 2025. The pharmaceutical will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate office and primary distribution operations. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. The parent contract serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a broad range of medications, vaccines, and medical supplies to support military healthcare programs and Defense Health Agency operations. As a major pharmaceutical distributor and critical federal vendor, AmerisourceBergen has demonstrated consistent capability to fulfill federal medical procurement requirements through competitive awards across multiple therapeutic domains, positioning it as a key supplier within the military's pharmaceutical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.2k | 9/4/25 |